根治性前列腺切除术后生化复发患者利用前列腺床磁共振成像所见局部复发前列腺癌评估长期临床进展风险
回顾性评估896例根治性前列腺切除术后生化复发男性,前列腺床磁共振成像阳性组441例、阴性组455例。影像阳性者无全身进展生存更长但前列腺癌特异性生存更短;病灶较大者前列腺癌死亡风险增加(HR 1.07)。
要点
- 影像阳性组无全身进展生存较阴性组更差(p=0.025)。
- 影像阳性组前列腺癌特异性生存较阴性组更差(p=0.016)。
- 病灶较大者前列腺癌死亡风险增加(HR 1.07,p<0.001)。
核心结论
- 前列腺床磁共振成像可为根治性前列腺切除术后生化复发患者的评估提供长期预后信息。
- 影像上有复发病灶的患者较无病灶者无进展生存更长但前列腺癌特异性生存更短。
- 病灶较大者与更差的前列腺癌特异性生存相关。
研究设计与样本
- 回顾性评估根治性前列腺切除术后生化复发、因疑似局部复发接受前列腺床磁共振成像的男性。
- 共纳入896例,影像阳性组441例、阴性组455例;成像时有淋巴结或骨病灶者排除。
- 采用Kaplan-Meier和Cox回归分析评估无全身进展生存和前列腺癌特异性生存。
主要发现
- 单因素分析显示术前前列腺特异抗原(p=0.02)、临床肿瘤分期(p=0.006)、根治性前列腺切除病理Gleason评分(p=0.02)、后续挽救性放疗(p<0.001)、生化复发至磁共振成像时间间隔(p<0.001)、磁共振成像时年龄(p=0.047)和磁共振成像时前列腺特异抗原(p<0.001)在影像阳性组与阴性组间有显著差异。
- 影像阴性组较影像阳性组无全身进展生存更差(p=0.025),但前列腺癌特异性生存更好(p=0.016)。
- 病灶较大者前列腺癌死亡风险增加(HR 1.07,p<0.001)。
- 多因素分析中,病理Gleason评分≥7是全身进展的独立预后因素(p<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our goal was to evaluate the long-term prognostic value of magnetic resonance imaging of the prostatectomy bed in patients with biochemical recurrence after radical prostatectomy for prostate cancer. MATERIALS AND METHODS: Men with biochemical recurrence after radical prostatectomy who were studied by prostatectomy bed magnetic resonance imaging for suspected local recurrence were retrospectively evaluated. Locally recurrent tumors were noted and measured from imaging reports. Patients with nodal/bone lesions at the time of imaging were excluded. Kaplan-Meier and Cox regression analyses were used to assess systemic progression-free and prostate cancer-specific survival. RESULTS: A total of 896 men were enrolled and the imaging positive and negative groups for local recurrent tumor consisted of 441 and 455 men, respectively. On univariate analysis, preoperative prostate specific antigen (p=0.02), clinical tumor stage (p=0.006), pathological Gleason score from prostatectomy (p=0.02), subsequent salvage radiotherapy (p <0.001), biochemical recurrence to magnetic resonance imaging time interval (p <0.001), age at magnetic resonance imaging (p=0.047) and prostate specific antigen at magnetic resonance imaging (p <0.001) were significantly different between magnetic resonance imaging positive and negative groups. Patients with negative magnetic resonance imaging results had worse systemic progression-free survival rates (p=0.025) and better prostate cancer-specific survival (p=0.016) than those with recurrence. Larger lesion size significantly increased risk of prostate cancer death (hazard ratio: 1.07; p <0.001). On multivariable analysis, pathological Gleason scores ≥7 were independent prognostic factors of systemic progression (p <0.05). CONCLUSIONS: Prostatectomy bed magnetic resonance imaging provides long-term prognostic information for the evaluation of patients with biochemical recurrence after prostatectomy. Post-prostatectomy patients with recurrent lesions on imaging had longer progression-free survival but shorter prostate cancer-specific survival compared to those without lesions. Additionally, those with larger lesions were associated with poorer cancer-specific survival.
引用
- Tanaka T, Kawashima A, Rangel LJ, et al. Long-Term Risk of Clinical Progression Utilizing Magnetic Resonance Imaging Findings of Locally Recurrent Prostate Cancer in Patients with Biochemical Recurrence following Radical Prostatectomy. J Urol. 2022. PMID: 34981952. doi:10.1097/JU.0000000000002421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。